Exploring a technique for reducing the influence of scattered rays from surrounding organs to the heart during myocardial perfusion scintigraphy with technetium-99m sestamibi and technetium-99m tetrofosmin

2006 ◽  
Vol 20 (10) ◽  
pp. 705-710 ◽  
Author(s):  
Hajime Monzen ◽  
Makoto Hirata ◽  
Akira Nakanishi ◽  
Makoto Ogasawara ◽  
Takatoshi Suzuki ◽  
...  
Keyword(s):  
Myocardial Perfusion ◽  
Myocardial Perfusion Scintigraphy ◽  
Technetium 99M Sestamibi ◽  
Perfusion Scintigraphy ◽  
Technetium 99M ◽  
Technetium 99M Tetrofosmin

Use of Technetium-99m-Labeled Lipophilic Complex of Methoxy-Isobutyl-Isonitrile and Iopromide Radiopaque Substance to Assess the Severity of Coronary Atherosclerosis in Patients with Coronary Heart Disease at Mild Disorders of Myocardial Perfusion

2015 ◽  
Vol 1084 ◽  
pp. 527-531
Author(s):  
Konstantin V. Zavadovsky ◽  
Marina O. Gulya ◽  
Yuriy B. Lishmanov ◽  
Vera V. Verkhoturova
Keyword(s):  
Computed Tomography ◽  
Coronary Artery Disease ◽  
Myocardial Perfusion ◽  
Coronary Atherosclerosis ◽  
Myocardial Perfusion Scintigraphy ◽  
Perfusion Scintigraphy ◽  
Significant Stenosis ◽  
Technetium 99M ◽  
Coronary Events ◽  
Artery Disease

In this study we used technetium-99m-labeled lipophilic complex of methoxy-isobutyl-isonitrile (99mTc-MIBI) and iopromide to assess coronary atherosclerosis in patients with coronary artery disease (CAD). The study included 33 patients with CAD who underwent myocardial perfusion scintigraphy with 99mTc-MIBI and computed tomography angiography (MDCTA) with iopromide. Patients who have comparable with the population-wide level risk of coronary events are characterized by the presence of borderline and significant stenosis 83% and 86%, respectively. 99mTc-MIBI and iopromide can be used to assess the severity of coronary atherosclerosis in patients with CAD.

Radiopharmaceuticals used in myocardial perfusion scintigraphy

2017 ◽  
Author(s):  
Nikant Sabharwal ◽  
Parthiban Arumugam ◽  
Andrew Kelion
Keyword(s):  
Myocardial Perfusion ◽  
Myocardial Perfusion Scintigraphy ◽  
Thallium 201 ◽  
Clinical Use ◽  
Perfusion Scintigraphy ◽  
Technetium 99M ◽  
99Mtc Tetrofosmin ◽  
99Mtc Sestamibi

Three radiopharmaceuticals are in routine clinical use in myocardial perfusion scintigraphy: thallium-201 (201Tl) as thallous chloride, technetium-99m (99mTc) sestamibi, and 99mTc tetrofosmin. This chapter covers physiological, imaging, and practical considerations of these radiopharmaceuticals, with detail on the properties and protocols of each explored in detail. Other perfusion tracers not in current clinical use are also listed.

Sign in / Sign up

Export Citation Format

Share Document